- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 29.77M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 29.81M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 30.06M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $4.81M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $1.13M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $8.37M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $8.15M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $23.88M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $26.36M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $254.05M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $212.84M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $329M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $304.8M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $802.82M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $796.39M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $751.49M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $732.17M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $7.04B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $7.07B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.84B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.87B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.75 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.58 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.76 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.59 |
| Net Income | Q1 2026 · Mar 31, 2026 | $22.56M |
| Net Income | Q1 2026 · Mar 31, 2025 | $17.67M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $22.56M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $17.67M |
| Revenue | Q1 2026 · Mar 31, 2026 | $71.74M |
| Revenue | Q1 2026 · Mar 31, 2025 | $62.82M |